We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Automated Modular Platform Processes Nucleic Acids and Proteins

By Biotechdaily staff writers
Posted on 07 Feb 2008
A novel modular platform offers laboratories a new level of flexibility and safety in automated processing of a broad range of samples. More...


Called the QIAsymphony SP, the platform allows users to load samples in different formats, and to isolate, purify, and prepare target analytes for analysis. This step is the most challenging of any molecular analysis. QIAsymphony SP was designed to meet a labs' flexibility and workflow needs. The system can handle a large variety of starting materials and a wide range of input volumes. More than 40 protocols to process DNA, RNA, and proteins have been optimized for use on the platform.

QIAsymphony SP is the first system in Qiagen's (Frankfurt, Germany) new series of modular instruments that can be integrated to automate entire workflows. The novel platform is the result of the largest development program ever undertaken at Qiagen.

The system incorporates many new features such as processing continuous sample racks, reagents, and consumables, and has the ability to perform several purification procedures on one batch of samples by reloading reagents. The system has a wide bandwidth of throughput settings, from a few a day to several hundred. The most complicated processes can be operated by a novice and there is no need retrain laboratory staff. Convenient touch screen operations and bar codes allow easy tracking of reagents, guaranteeing maximum safety and reproducible results.

QIAsymphony SP received the New Product Award (NPA) Designation of the Association for Laboratory Automation (ALA; Geneva, IL, USA). The award was presented to Qiagen on January 29, 2008, at LabAutomation in Palm Springs, CA (USA); an international conference and exhibit for laboratory technologies, where QIAsymphony SP was officially launched on January 28.



Related Links:
Qiagen
Association for Laboratory Automation

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.